Date published: 
6 May 2021
Intended audience: 
General public

ATAGI met on 4 May 2021 to review the latest developments relating to the AstraZeneca COVID-19 vaccine and Thrombosis and Thrombocytopenia Syndrome (TTS) cases in Australia and overseas.

ATAGI considered the current status of TTS cases in Australia and internationally. Read the latest TGA COVID-19 vaccine weekly safety report.

At this time, there is no update to the ATAGI statement from 23 April 2021 in relation to the use of the AstraZeneca COVID-19 vaccine.

ATAGI continue to be regularly updated by the TGA on the TTS cases under investigation in Australia and is utilising both confirmed TTS case rates and international data to inform recommendations for AstraZeneca COVID-19 vaccine use.